Why HBV Screening Matters Before HCV Direct-Acting Antivirals
A 2017 systematic review and meta-analysis examined the growing concern about hepatitis B (HBV) reactivation in people with chronic hepatitis C (HCV) who are coinfected with HBV and treated with modern, all-oral direct-acting antivirals (DAAs).
